Open AccessThe Role of 18F-FDG PET/CT in Evaluating Elevated Levels of Tumor Markers in Breast Cancer
Author(s) -
İnan Göktaş,
Hakan Cayvarlı
Publication year - 2018
Publication title -
molecular imaging and radionuclide therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.292
H-Index - 7
eISSN - 2147-1959
pISSN - 2146-1414
DOI - 10.4274/mirt.74436
Subject(s) - medicine , carcinoembryonic antigen , breast cancer , positron emission tomography , radiology , pathological , cancer , nuclear medicine , pet ct , tumor marker , metastasis
Our aim was to assess the diagnostic performance of integrated positron emission tomography/computed tomography (PET/CT) in the follow-up of breast cancer patients, who underwent a PET/CT scan due to a suspicion of recurrence based on elevated levels of serum tumor markers.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom